Symbols / PULM $1.40 +1.45% Pulmatrix, Inc.

Healthcare • Biotechnology • United States • NCM
PULM Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.

Fundamentals
Scroll to Statements
Market Cap 5.11M Enterprise Value 1.03M Income -5.16M Sales — Book/sh 1.04 Cash/sh 1.12
Dividend Yield — Payout 0.00% Employees 2 IPO — P/E — Forward P/E -0.31
PEG — P/S — P/B 1.34 P/C — EV/EBITDA -0.20 EV/Sales —
Quick Ratio 12.43 Current Ratio 12.55 Debt/Eq — LT Debt/Eq — EPS (ttm) -1.41 EPS next Y -4.50
EPS Growth — Revenue Growth — Earnings 2023-11-09 ROA -45.88% ROE -80.93% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 3.65M Shs Float 3.63M Short Float 0.22%
Short Ratio 0.08 Short Interest — 52W High 9.37 52W Low 1.16 Beta 1.97 Avg Volume 49.74K
Volume 32.92K Target Price — Recom None Prev Close $1.38 Price $1.40 Change 1.45%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.40
Latest analyst target
3. DCF / Fair value
$-16.99
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.40
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2023-08-15 reit HC Wainwright & Co. Buy → Buy $10
2023-05-15 reit HC Wainwright & Co. Buy → Buy $10
2023-02-07 reit HC Wainwright & Co. — → Buy $10
2022-03-30 main HC Wainwright & Co. — → Buy $10
News
RSS: Latest PULM news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
-100.00%
7.81
+6.96%
7.30
+20.21%
6.07
Operating Revenue
0.00
-100.00%
7.81
+6.96%
7.30
+20.21%
6.07
Operating Expense
5.17
-65.43%
14.95
-32.16%
22.04
-11.91%
25.02
Research And Development
0.04
-99.47%
7.17
-53.82%
15.52
-14.92%
18.24
Selling General And Administration
5.13
-34.09%
7.79
+19.40%
6.52
-3.81%
6.78
General And Administrative Expense
5.13
-34.09%
7.79
+19.40%
6.52
-3.81%
6.78
Other Gand A
5.13
-34.09%
7.79
+19.40%
6.52
-3.81%
6.78
Total Expenses
5.17
-65.43%
14.95
-32.16%
22.04
-11.91%
25.02
Operating Income
-5.17
+27.66%
-7.14
+51.53%
-14.74
+22.20%
-18.95
Total Operating Income As Reported
-5.17
+47.06%
-9.76
+33.77%
-14.74
+22.20%
-18.95
EBITDA
-5.17
+22.97%
-6.71
+49.42%
-13.27
+23.77%
-17.40
Normalized EBITDA
-5.24
-30.09%
-4.03
+69.66%
-13.27
+23.77%
-17.40
Reconciled Depreciation
0.00
-100.00%
0.43
-70.51%
1.48
-4.53%
1.54
EBIT
-5.17
+27.66%
-7.14
+51.53%
-14.74
+22.20%
-18.95
Total Unusual Items
0.07
+102.50%
-2.69
0.00
0.00
Total Unusual Items Excluding Goodwill
0.07
+102.50%
-2.69
0.00
0.00
Special Income Charges
0.00
+100.00%
-2.62
0.00
0.00
Impairment Of Capital Assets
—
—
—
0.00
Net Income
-5.16
+46.00%
-9.56
+32.31%
-14.12
+25.03%
-18.84
Pretax Income
-5.16
+46.00%
-9.56
+32.31%
-14.12
+25.03%
-18.84
Net Non Operating Interest Income Expense
0.14
-69.16%
0.47
-46.14%
0.87
+180.58%
0.31
Net Interest Income
0.14
-69.16%
0.47
-46.14%
0.87
+180.58%
0.31
Interest Income Non Operating
0.14
-69.16%
0.47
-46.14%
0.87
+180.58%
0.31
Interest Income
0.14
-69.16%
0.47
-46.14%
0.87
+180.58%
0.31
Other Income Expense
-0.14
+95.24%
-2.88
-1061.69%
-0.25
-25.25%
-0.20
Other Non Operating Income Expenses
-0.20
-4.08%
-0.20
+20.97%
-0.25
-25.25%
-0.20
Gain On Sale Of Security
0.07
+200.00%
-0.07
—
—
Gain On Sale Of Business
0.00
+100.00%
-2.62
0.00
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-5.16
+46.00%
-9.56
+32.31%
-14.12
+25.03%
-18.84
Net Income From Continuing Operation Net Minority Interest
-5.16
+46.00%
-9.56
+32.31%
-14.12
+25.03%
-18.84
Net Income From Continuing And Discontinued Operation
-5.16
+46.00%
-9.56
+32.31%
-14.12
+25.03%
-18.84
Net Income Continuous Operations
-5.16
+46.00%
-9.56
+32.31%
-14.12
+25.03%
-18.84
Normalized Income
-5.23
+23.93%
-6.87
+51.32%
-14.12
+25.03%
-18.84
Net Income Common Stockholders
-5.16
+46.00%
-9.56
+32.31%
-14.12
+25.03%
-18.84
Diluted EPS
-1.41
+46.18%
-2.62
+32.30%
-3.87
+29.12%
-5.46
Basic EPS
-1.41
+46.18%
-2.62
+32.30%
-3.87
+29.12%
-5.46
Basic Average Shares
3.65
+0.00%
3.65
+0.01%
3.65
+5.92%
3.45
Diluted Average Shares
3.65
+0.00%
3.65
+0.01%
3.65
+5.92%
3.45
Diluted NI Availto Com Stockholders
-5.16
+46.00%
-9.56
+32.31%
-14.12
+25.03%
-18.84
Preferred Stock Dividends
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
4.14
-58.37%
9.94
-70.72%
33.96
-17.08%
40.95
Current Assets
4.13
-58.38%
9.92
-52.41%
20.84
-45.36%
38.15
Cash Cash Equivalents And Short Term Investments
4.09
-57.06%
9.52
-50.34%
19.17
-46.19%
35.63
Cash And Cash Equivalents
4.09
-57.06%
9.52
-50.34%
19.17
-46.19%
35.63
Receivables
—
0.00
-100.00%
0.93
-28.51%
1.30
Accounts Receivable
—
0.00
-100.00%
0.93
-28.51%
1.30
Prepaid Assets
0.01
-96.80%
0.22
-40.81%
0.37
-58.98%
0.90
Restricted Cash
—
—
0.00
-100.00%
0.15
Other Current Assets
0.03
-81.11%
0.18
-51.61%
0.37
+124.10%
0.17
Total Non Current Assets
0.01
-56.52%
0.02
-99.82%
13.12
+367.39%
2.81
Net PPE
—
0.00
-100.00%
11.47
+1113.44%
0.94
Gross PPE
—
0.00
-100.00%
13.20
+257.51%
3.69
Accumulated Depreciation
—
0.00
+100.00%
-1.74
+36.83%
-2.75
Properties
—
0.00
0.00
0.00
Machinery Furniture Equipment
—
0.00
-100.00%
0.64
+29.67%
0.49
Construction In Progress
—
0.00
-100.00%
0.60
0.00
Other Properties
—
—
11.96
+371.62%
2.54
Leases
—
0.00
0.00
-100.00%
0.66
Goodwill And Other Intangible Assets
—
—
—
—
Goodwill
—
—
—
—
Other Non Current Assets
0.01
-56.52%
0.02
-98.60%
1.65
-11.45%
1.86
Total Liabilities Net Minority Interest
0.33
-66.97%
1.00
-93.76%
15.96
+62.16%
9.84
Current Liabilities
0.33
-64.59%
0.93
-76.23%
3.91
-22.16%
5.02
Payables And Accrued Expenses
0.32
-63.29%
0.86
-68.95%
2.76
-1.07%
2.79
Payables
0.27
-66.38%
0.81
-57.75%
1.92
+61.20%
1.19
Accounts Payable
0.27
-66.38%
0.81
-57.75%
1.92
+61.20%
1.19
Current Accrued Expenses
0.04
-12.24%
0.05
-94.22%
0.85
-47.17%
1.60
Current Debt And Capital Lease Obligation
—
—
0.43
-49.94%
0.86
Current Capital Lease Obligation
—
0.00
-100.00%
0.43
-49.94%
0.86
Current Deferred Liabilities
—
0.00
-100.00%
0.62
-53.85%
1.34
Current Deferred Revenue
—
0.00
-100.00%
0.62
-53.85%
1.34
Other Current Liabilities
0.01
-80.28%
0.07
-28.28%
0.10
+200.00%
0.03
Total Non Current Liabilities Net Minority Interest
0.00
-100.00%
0.07
-99.44%
12.05
+149.98%
4.82
Long Term Debt And Capital Lease Obligation
—
0.00
-100.00%
8.33
0.00
Long Term Capital Lease Obligation
—
0.00
-100.00%
8.33
0.00
Non Current Deferred Liabilities
—
0.00
-100.00%
3.73
-22.71%
4.82
Non Current Deferred Revenue
—
0.00
-100.00%
3.73
-22.71%
4.82
Stockholders Equity
3.81
-57.42%
8.95
-50.28%
18.00
-42.16%
31.11
Common Stock Equity
3.81
-57.42%
8.95
-50.28%
18.00
-42.16%
31.11
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
3.65
+0.00%
3.65
+0.00%
3.65
+0.36%
3.64
Ordinary Shares Number
3.65
+0.00%
3.65
+0.00%
3.65
+0.36%
3.64
Additional Paid In Capital
306.13
+0.01%
306.10
+0.17%
305.59
+0.33%
304.58
Retained Earnings
-302.32
-1.74%
-297.16
-3.32%
-287.60
-5.16%
-273.48
Total Equity Gross Minority Interest
3.81
-57.42%
8.95
-50.28%
18.00
-42.16%
31.11
Total Capitalization
3.81
-57.42%
8.95
-50.28%
18.00
-42.16%
31.11
Working Capital
3.80
-57.74%
8.99
-46.91%
16.93
-48.88%
33.12
Invested Capital
3.81
-57.42%
8.95
-50.28%
18.00
-42.16%
31.11
Total Debt
—
0.00
-100.00%
8.76
+921.70%
0.86
Capital Lease Obligations
—
0.00
-100.00%
8.76
+921.70%
0.86
Net Tangible Assets
3.81
-57.42%
8.95
-50.28%
18.00
-42.16%
31.11
Tangible Book Value
3.81
-57.42%
8.95
-50.28%
18.00
-42.16%
31.11
Derivative Product Liabilities
0.00
-100.00%
0.07
0.00
—
Preferred Stock Equity
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-5.43
+49.30%
-10.72
+32.96%
-15.98
+17.42%
-19.36
Cash Flow From Continuing Operating Activities
-5.43
+49.30%
-10.72
+32.96%
-15.98
+17.42%
-19.36
Net Income From Continuing Operations
-5.16
+46.00%
-9.56
+32.31%
-14.12
+25.03%
-18.84
Depreciation Amortization Depletion
0.00
-100.00%
0.43
-70.51%
1.48
-4.53%
1.54
Depreciation
0.00
-100.00%
0.43
-70.51%
1.48
-4.53%
1.54
Depreciation And Amortization
0.00
-100.00%
0.43
-70.51%
1.48
-4.53%
1.54
Stock Based Compensation
0.03
-95.11%
0.51
-46.44%
0.95
-14.36%
1.11
Asset Impairment Charge
—
—
—
0.00
Operating Gains Losses
-0.07
-102.50%
2.69
+33462.50%
0.01
—
Gain Loss On Investment Securities
-0.07
-200.00%
0.07
—
—
Gain Loss On Sale Of PPE
—
—
0.01
0.00
Change In Working Capital
-0.23
+95.22%
-4.79
-11.32%
-4.30
-35.29%
-3.18
Change In Receivables
0.00
-100.00%
0.93
+150.81%
0.37
+130.06%
-1.23
Changes In Account Receivables
0.00
-100.00%
0.93
+150.81%
0.37
+130.06%
-1.23
Change In Prepaid Assets
0.36
+4.37%
0.34
+5.21%
0.33
+265.48%
-0.20
Change In Payables And Accrued Expense
-0.60
+61.14%
-1.54
-337.39%
-0.35
-138.54%
0.92
Change In Accrued Expense
-0.06
+85.62%
-0.44
+59.44%
-1.08
-366.67%
0.41
Change In Payable
-0.54
+51.45%
-1.11
-252.13%
0.73
+42.27%
0.51
Change In Account Payable
-0.54
+51.45%
-1.11
-252.13%
0.73
+42.27%
0.51
Change In Other Working Capital
—
-4.34
-139.26%
-1.82
-114.40%
-0.85
Change In Other Current Assets
0.01
-92.02%
0.16
-23.47%
0.21
+154.76%
-0.39
Change In Other Current Liabilities
0.00
+100.00%
-0.33
+89.05%
-3.04
-112.51%
-1.43
Investing Cash Flow
0.00
+100.00%
-0.40
+41.12%
-0.68
-686.05%
-0.09
Cash Flow From Continuing Investing Activities
0.00
+100.00%
-0.40
+41.12%
-0.68
-686.05%
-0.09
Net PPE Purchase And Sale
0.00
+100.00%
-0.40
+41.12%
-0.68
-686.05%
-0.09
Purchase Of PPE
0.00
+100.00%
-0.40
+41.12%
-0.68
-686.05%
-0.09
Capital Expenditure
—
-0.40
+41.12%
-0.68
-686.05%
-0.09
Financing Cash Flow
—
0.00
-100.00%
0.05
-95.69%
1.23
Cash Flow From Continuing Financing Activities
—
0.00
-100.00%
0.05
-95.69%
1.23
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
—
—
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
—
0.00
-100.00%
0.05
-96.16%
1.38
Repurchase Of Capital Stock
—
—
—
-0.15
Proceeds From Stock Option Exercised
—
—
—
0.00
Net Other Financing Charges
—
—
—
-0.15
Changes In Cash
-5.43
+51.12%
-11.11
+33.08%
-16.61
+8.81%
-18.21
Beginning Cash Position
9.53
-53.83%
20.64
-44.58%
37.25
-32.84%
55.47
End Cash Position
4.10
-57.00%
9.53
-53.83%
20.64
-44.58%
37.25
Free Cash Flow
-5.43
+51.12%
-11.11
+33.29%
-16.66
+14.30%
-19.44
Common Stock Issuance
—
0.00
-100.00%
0.05
-96.16%
1.38
Issuance Of Capital Stock
—
0.00
-100.00%
0.05
-96.16%
1.38
Net Preferred Stock Issuance
—
—
—
-0.15
Preferred Stock Issuance
—
—
—
—
Preferred Stock Payments
—
—
—
-0.15
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category